Buyout Bid Overshadows NxStage Medical's Losses

03:17 EDT 8 Aug 2017 | Topix

Even though some investors had recently started to worry about the prospects for fast growth from the company , NxStage got a huge vote of confidence from Fresenius Medical Care Coming into Monday's second-quarter financial report, NxStage investors had no inkling that a merger would be right around the corner, and they had mixed expectations about how much growth the medical device maker would be able to produce. NxStage's numbers were a bit disappointing, but all that is likely to pale in comparison to the importance of the proposed acquisition.

Original Article: Buyout Bid Overshadows NxStage Medical's Losses


More From BioPortfolio on "Buyout Bid Overshadows NxStage Medical's Losses"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...